Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Condition:   Triple Negative Breast Cancer Interventions:   Drug: Gemcitabine and carboplatin plus antibiotic (moxifloxacin);   Drug: Gemcitabine combined with carboplatin plus placebo Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2021 Category: Research Source Type: clinical trials

Effects of moxifloxacin and gemifloxacin on blood glucose level of euglycemics:a pre-clinical and clinical study
Conditions:   Dysglycemia;   Blood Glucose, Low Interventions:   Drug: Moxifloxacin 400mg;   Drug: Gemifloxacin 320 MG Sponsor:   Shaheed Benazir Bhutto University Sheringal Dir Upper Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2021 Category: Research Source Type: clinical trials

Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
Conditions:   Symptomatic Neurogenic Orthostatic Hypertension;   nOH Interventions:   Drug: Ampreloxetine ;   Drug: Ampreloxetine ;   Drug: Ampreloxetine Placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin Placebo Sponsor:   Theravance Biopharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2020 Category: Research Source Type: clinical trials

A Study of the Cardiac Effects of ALXN2050 in Healthy Adults
Condition:   Healthy Interventions:   Drug: ALXN2050;   Drug: ALXN2050-matching Placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin-matching Placebo Sponsors:   Alexion Pharmaceuticals;   Celerion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2020 Category: Research Source Type: clinical trials

Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin
Condition:   HIV Infections Interventions:   Drug: GSK3640254;   Drug: Placebo;   Drug: Moxifloxacin Sponsor:   ViiV Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2020 Category: Research Source Type: clinical trials

A Study of the Cardiac Effects of ALXN1840 in Healthy Adults
Condition:   Healthy Interventions:   Drug: ALXN1840;   Drug: Placebo;   Drug: Moxifloxacin Sponsors:   Alexion Pharmaceuticals;   PPD;   ERT: Clinical Trial Technology Solutions Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2020 Category: Research Source Type: clinical trials

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
Conditions:   Infections and Infestations;   Pulmonary Tuberculosis Interventions:   Drug: Delpazolid;   Drug: Bedaquiline, Delamanid, Moxifloxacin Sponsors:   LegoChem Biosciences, Inc;   Ludwig-Maximilians - University of Munich;   Radboud University;   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials